[144] ROKU, INC SEC Filing

Rhea-AI Filing Summary

ROKU, INC. insider sales notice reports that 112,961 shares of common stock are proposed for sale through Morgan Stanley Smith Barney on 10/01/2025, with an aggregate market value of $11,861,089.84. The filing shows these shares were acquired the same day by stock option exercise and paid in cash. The filer also disclosed four sales in the prior three months totaling 256,458 shares and gross proceeds of approximately $23,307,798.99, including a single sale of 212,559 shares on 07/21/2025 for $20,193,161.48. The notice includes the required attestation that the seller is not aware of undisclosed material adverse information.

Positive

• None.

Negative

• Large insider sale activity: Proposed sale of 112,961 shares (~$11.86M) and prior three-month sales totaling 256,458 shares (~$23.31M) may increase available float.
• No 10b5-1 plan indicated: Filing does not state a trading-plan adoption date, so sales are presented as open-market transactions without explicit pre-established plan protection.

Insights

Securities Analyst

TL;DR: Significant insider selling disclosed—large option exercise and immediate proposed sale may affect short-term float and perceptions.

The filing documents an insider stock option exercise and immediate proposed sale of 112,961 shares valued at about $11.86M. Recent historical sales of 256,458 shares in the prior three months show active monetization by the same seller, including a large 212,559 share sale on 07/21/2025. For investors this is a clear disclosure of insider liquidity events rather than operational information; the filing does not state any material nonpublic information or reasons for the sales beyond exercise and cash payment.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 mechanics; repeated sales warrant monitoring but show procedural transparency.

The notice records acquisition via stock option exercise and subsequent proposed sale through a registered broker. The filer provided past three months' sales with exact proceeds, meeting disclosure norms. The document includes the standard representation about absence of undisclosed material adverse information. There is no mention of a 10b5-1 plan or other trading plan in the filing, so no formal trading-plan protection is asserted in this notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	112961	11861089.84	147330633	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Stock Option Exercise	ISSUER			112961	10/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHARLES COLLIER 1173 Coleman Avenue San Jose CA 95110	Common	09/04/2025	10269	1018079.96
CHARLES COLLIER 1173 Coleman Avenue San Jose CA 95110	Common	09/03/2025	14361	1394002.51
CHARLES COLLIER 1173 Coleman Avenue San Jose CA 95110	Common	08/22/2025	10269	975555.00
CHARLES COLLIER 1173 Coleman Avenue San Jose CA 95110	Common	07/21/2025	212559	20193161.48

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transaction did ROKU report in this Form 144?

The filer reported a proposed sale of 112,961 common shares to be sold on 10/01/2025 through Morgan Stanley Smith Barney, with aggregate market value $11,861,089.84.

How were the shares acquired that are proposed for sale?

The shares were acquired on 10/01/2025 by a stock option exercise from the issuer, with payment made in cash.

Has the filer sold other ROKU shares recently?

Yes. The filing lists four sales in the prior three months totaling 256,458 shares with gross proceeds of about $23,307,798.99, including 212,559 shares sold on 07/21/2025 for $20,193,161.48.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the filing state the seller knows of any undisclosed material information?

The notice includes the seller's representation that they do not know any material adverse information about the issuer that has not been publicly disclosed.